Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Dev and Doc: AI For Healthcare Podcast

#25 Testing Deepseek R1 on Complex Medical Tasks. Here's what we found. (GRPO explainer)

07 Feb 2025

Description

Dev and Doc put Deepseek R1 to the test in a technical and clinical deep dive. ๐Ÿ‘‹ Hey! If you are enjoying our conversations, reach out, share your thoughts and journey with us. Don't forget to subscribe whilst you're here :) ๐Ÿ‘จ๐Ÿปโ€โš•๏ธDoc - Dr. Joshua Au Yeung - https://www.linkedin.com/in/dr-joshua-au-yeung/ ๐Ÿค–Dev - Zeljko Kraljevic https://twitter.com/zeljkokr TIMESTAMPS 00:00 Highlights 04:36 Intro 08:29 response from OpenAI, Anthropic- model training costs, tightening restrictions on China, pricing wars 13:13 what an open-source deepseek means for the world. 15:38 Sam altman and Dario amodei feeling the pressure 23:10 TECHNICAL deep dive - RLHF, ppo, dpo 37:08 GRPO, R1s secret sauce 45:02 the aha moment, learning like a human? 50:25 deepseek R1 training and controversy 59:08 deepseek healthcare evaluation - Ethnic Bias 1:06:17 The diagnostic acid test (fail) 1:12:46 Coding clinical data / Medical billing (shout out SNOMED) LinkedIn Newsletter https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=7216474068085026817 YT - https://youtube.com/@DevAndDoc Spotify - https://podcasters.spotify.com/pod/show/devanddoc Apple- https://podcasts.apple.com/gb/podcast/dev-and-doc-ai-for-healthcare-podcast/id1751495120 Substack- https://aiforhealthcare.substack.com/ For enquiries - ๐Ÿ“ง[email protected] ๐ŸŽž๏ธ Editor- Dragan Kraljeviฤ‡ https://www.instagram.com/dragan_kraljevic/ ๐ŸŽจBrand design and art direction - Ana Grigorovici https://www.behance.net/anagrigorovici027d

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
๐Ÿ—ณ๏ธ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.